Align Technology, Inc. $ALGN Position Lowered by Universal Beteiligungs und Servicegesellschaft mbH

Universal Beteiligungs und Servicegesellschaft mbH reduced its position in Align Technology, Inc. (NASDAQ:ALGN) by 23.0% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 124,203 shares of the medical equipment provider’s stock after selling 37,204 shares during the quarter. Universal Beteiligungs und Servicegesellschaft mbH’s holdings in Align Technology were worth $15,553,000 at the end of the most recent quarter.

Other large investors also recently bought and sold shares of the company. Ninety One UK Ltd grew its position in shares of Align Technology by 18.3% in the 3rd quarter. Ninety One UK Ltd now owns 2,267,192 shares of the medical equipment provider’s stock worth $283,898,000 after acquiring an additional 350,883 shares in the last quarter. Federated Hermes Inc. lifted its stake in Align Technology by 31.0% during the second quarter. Federated Hermes Inc. now owns 926,733 shares of the medical equipment provider’s stock worth $175,458,000 after purchasing an additional 219,219 shares during the last quarter. Disciplined Growth Investors Inc. MN lifted its stake in Align Technology by 0.9% during the second quarter. Disciplined Growth Investors Inc. MN now owns 844,987 shares of the medical equipment provider’s stock worth $159,981,000 after purchasing an additional 7,754 shares during the last quarter. Norges Bank acquired a new position in Align Technology in the second quarter worth $155,297,000. Finally, Navera Investment Management Ltd. increased its stake in Align Technology by 3.0% during the second quarter. Navera Investment Management Ltd. now owns 787,559 shares of the medical equipment provider’s stock valued at $149,126,000 after purchasing an additional 23,080 shares during the last quarter. Institutional investors own 88.43% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have recently issued reports on ALGN shares. HSBC raised their price target on shares of Align Technology from $140.00 to $150.00 in a research report on Friday, October 31st. Zacks Research upgraded Align Technology from a “strong sell” rating to a “hold” rating in a research note on Tuesday, September 30th. UBS Group dropped their price target on Align Technology from $160.00 to $155.00 and set a “neutral” rating on the stock in a research report on Thursday, October 16th. Mizuho boosted their price objective on Align Technology from $170.00 to $200.00 and gave the company an “outperform” rating in a research report on Tuesday. Finally, Barclays assumed coverage on Align Technology in a research report on Monday, December 8th. They issued an “equal weight” rating and a $170.00 target price on the stock. Six research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the stock. According to data from MarketBeat, Align Technology currently has an average rating of “Hold” and a consensus price target of $176.82.

Align Technology Stock Performance

NASDAQ:ALGN opened at $168.73 on Friday. The stock has a market cap of $12.11 billion, a price-to-earnings ratio of 32.70, a PEG ratio of 1.90 and a beta of 1.83. Align Technology, Inc. has a 1 year low of $122.00 and a 1 year high of $234.39. The business has a fifty day moving average of $157.96 and a 200-day moving average of $150.75.

Align Technology (NASDAQ:ALGN) last posted its quarterly earnings data on Wednesday, October 29th. The medical equipment provider reported $2.61 earnings per share for the quarter, topping the consensus estimate of $2.38 by $0.23. The business had revenue of $995.69 million during the quarter, compared to the consensus estimate of $980.75 million. Align Technology had a net margin of 9.50% and a return on equity of 13.96%. The company’s quarterly revenue was up 1.8% compared to the same quarter last year. During the same quarter in the prior year, the company posted $2.35 earnings per share. On average, equities research analysts predict that Align Technology, Inc. will post 7.98 EPS for the current year.

Align Technology Profile

Align Technology, Inc (NASDAQ: ALGN) pioneered the use of digital technology in orthodontics through the development of the Invisalign system, a series of clear, removable aligners that provide an alternative to traditional metal braces. Since its founding in 1997 by Zia Chishti and Kelsey Wirth, the Tempe, Arizona–based company has expanded its focus to include intraoral scanners, CAD/CAM software for dental laboratories and comprehensive digital dentistry solutions.

The company’s signature Invisalign system leverages 3D imaging and computer-aided design (CAD) to create customized aligners that gradually reposition teeth, improving patient comfort and treatment predictability.